» Articles » PMID: 36596323

Meeting Report: 35th International Conference on Antiviral Research in Seattle, Washington, USA - March 21-25, 2022

Overview
Journal Antiviral Res
Publisher Elsevier
Date 2023 Jan 3
PMID 36596323
Authors
Affiliations
Soon will be listed here.
Abstract

The 35th International Conference on Antiviral Research (ICAR), sponsored by the International Society for Antiviral Research (ISAR), was held in Seattle, Washington, USA, on March 21-25, 2022 and concurrently through an interactive remote meeting platform. This report gives an overview of the conference on behalf of the society. It provides a general review of the meeting and awardees, summarizing the presentations and their main conclusions from the perspective of researchers active in many different areas of antiviral research and development. Through ICAR, leaders in the field of antiviral research were able to showcase their efforts, as participants learned about key advances in the field. The impact of these efforts was exemplified by many presentations on SARS-CoV-2 demonstrating the remarkable response to the ongoing pandemic, as well as future pandemic preparedness, by members of the antiviral research community. As we address ongoing outbreaks and seek to mitigate those in the future, this meeting continues to support outstanding opportunities for the exchange of knowledge and expertise while fostering cross-disciplinary collaborations in therapeutic and vaccine development. The 36th ICAR will be held in Lyon, France, March 13-17, 2023.

Citing Articles

Meeting report of the 37th International Conference on Antiviral Research in Gold Coast, Australia, May 20-24, 2024, organized by the International Society for Antiviral Research.

Welch S, Bilello J, Carter K, Delang L, Dirr L, Durantel D Antiviral Res. 2024; 232:106037.

PMID: 39542140 PMC: 11871649. DOI: 10.1016/j.antiviral.2024.106037.


A comprehensive study of SARS-CoV-2 main protease (Mpro) inhibitor-resistant mutants selected in a VSV-based system.

Costacurta F, Dodaro A, Bante D, Schoppe H, Peng J, Sprenger B PLoS Pathog. 2024; 20(9):e1012522.

PMID: 39259728 PMC: 11407635. DOI: 10.1371/journal.ppat.1012522.


In Silico Assessment of Chemical Disinfectants on Surface Proteins Unveiled Dissimilarity in Antiviral Efficacy and Suitability towards Pathogenic Viruses.

Zure D, Sung M, Rahim A, Kuo H Int J Mol Sci. 2024; 25(11).

PMID: 38892197 PMC: 11172749. DOI: 10.3390/ijms25116009.


A comprehensive study of SARS-CoV-2 main protease (M) inhibitor-resistant mutants selected in a VSV-based system.

Costacurta F, Dodaro A, Bante D, Schoppe H, Sprenger B, Moghadasi S bioRxiv. 2023; .

PMID: 37808638 PMC: 10557589. DOI: 10.1101/2023.09.22.558628.


Meeting report: 36th International Conference on Antiviral Research in Lyon, France - March 13-17, 2023.

Spengler J, Carter K, Delang L, Durantel D, Gowen B, Herrero L Antiviral Res. 2023; 217:105678.

PMID: 37494979 PMC: 11268725. DOI: 10.1016/j.antiviral.2023.105678.


References
1.
Tramontano E, Tarbet B, Spengler J, Seley-Radtke K, Meier C, Jordan R . Meeting report: 32nd International Conference on Antiviral Research. Antiviral Res. 2019; 169:104550. PMC: 7105345. DOI: 10.1016/j.antiviral.2019.104550. View

2.
Vere Hodge R . Meeting report: 26th International Conference on Antiviral Research. Antiviral Res. 2013; 100(1):276-85. PMC: 7126960. DOI: 10.1016/j.antiviral.2013.08.006. View

3.
Vere Hodge R . Meeting report: 27th International conference on antiviral research, in Raleigh, NC, USA. Antiviral Res. 2014; 111:143-53. PMC: 7119014. DOI: 10.1016/j.antiviral.2014.08.009. View

4.
Hodge A . Antiviral Research--16th Annual International Conference. Satellite symposium: clinical update on antiviral drugs. 27 April-1 May 2003, Savannah, GA, USA. IDrugs. 2003; 6(6):515-7. View

5.
Hodge A . Antiviral Research--16th International Conference: 27 April-1 May 2003, Savannah, GA, USA. IDrugs. 2003; 6(6):512-4. View